Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV002468458 | SCV002764327 | uncertain significance | Type 2 diabetes mellitus; Hyperinsulinism due to glucokinase deficiency; Maturity-onset diabetes of the young type 2 | 2021-09-10 | criteria provided, single submitter | clinical testing | The heterozygous c.278A>C (p.Glu93Ala) missense variant identified in the GCK gene has not been reported in the literature. This variant is absent in the gnomAD (v3) database suggesting it is not a common benign variant in the populations represented in that database. The variant affects a moderately conserved residue (Glu93) of the GCK gene and is predicted deleterious by multiple in silico tools (CADD score = 22.1, REVEL score = 0.711). Due to the lack of compelling evidence for its pathogenicity, the heterozygous c.278A>C (p.Glu93Ala) missense variant identified in the GCK gene is reported as aVariant of Uncertain Significance. |